86 related articles for article (PubMed ID: 25503119)
1. Evaluation of a special combination of glucan with organic selenium derivative in different murine tumor models.
Vetvicka V; Pinatto-Botelho MF; Dos Santos AA; De Oliveira CA
Anticancer Res; 2014 Dec; 34(12):6939-44. PubMed ID: 25503119
[TBL] [Abstract][Full Text] [Related]
2. Combination of glucan, resveratrol and vitamin C demonstrates strong anti-tumor potential.
Vetvicka V; Vetvickova J
Anticancer Res; 2012 Jan; 32(1):81-7. PubMed ID: 22213291
[TBL] [Abstract][Full Text] [Related]
3. Beta-glucan functions as an adjuvant for monoclonal antibody immunotherapy by recruiting tumoricidal granulocytes as killer cells.
Hong F; Hansen RD; Yan J; Allendorf DJ; Baran JT; Ostroff GR; Ross GD
Cancer Res; 2003 Dec; 63(24):9023-31. PubMed ID: 14695221
[TBL] [Abstract][Full Text] [Related]
4. Beta-glucan, a "specific" biologic response modifier that uses antibodies to target tumors for cytotoxic recognition by leukocyte complement receptor type 3 (CD11b/CD18).
Yan J; Vetvicka V; Xia Y; Coxon A; Carroll MC; Mayadas TN; Ross GD
J Immunol; 1999 Sep; 163(6):3045-52. PubMed ID: 10477568
[TBL] [Abstract][Full Text] [Related]
5. Effect of yeast-derived beta-glucan in conjunction with bevacizumab for the treatment of human lung adenocarcinoma in subcutaneous and orthotopic xenograft models.
Zhong W; Hansen R; Li B; Cai Y; Salvador C; Moore GD; Yan J
J Immunother; 2009 Sep; 32(7):703-12. PubMed ID: 19561538
[TBL] [Abstract][Full Text] [Related]
6. Glucans and Cancer: Comparison of Commercially Available β-glucans - Part IV.
Vetvicka V; Vetvickova J
Anticancer Res; 2018 Mar; 38(3):1327-1333. PubMed ID: 29491056
[TBL] [Abstract][Full Text] [Related]
7. Natural immunomodulators and their stimulation of immune reaction: true or false?
Vetvicka V; Vetvickova J
Anticancer Res; 2014 May; 34(5):2275-82. PubMed ID: 24778031
[TBL] [Abstract][Full Text] [Related]
8. Increased efficiency of Lewis lung carcinoma chemotherapy with a macrophage stimulator--yeast carboxymethyl glucan.
Kogan G; Sandula J; Korolenko TA; Falameeva OV; Poteryaeva ON; Zhanaeva SY; Levina OA; Filatova TG; Kaledin VI
Int Immunopharmacol; 2002 May; 2(6):775-81. PubMed ID: 12095168
[TBL] [Abstract][Full Text] [Related]
9. Potential of the aminosterol, squalamine in combination therapy in the rat 13,762 mammary carcinoma and the murine Lewis lung carcinoma.
Teicher BA; Williams JI; Takeuchi H; Ara G; Herbst RS; Buxton D
Anticancer Res; 1998; 18(4A):2567-73. PubMed ID: 9703911
[TBL] [Abstract][Full Text] [Related]
10. Macrophage Stimulator beta-(1-->3)-D-carboxymethylglucan improves the efficiency of chemotherapy of Lewis lung carcinoma.
Falameeva OV; Poteryaeva ON; Zhanaeva SY; Levina OA; Filatova TG; Korolenko TA; Kaledin VI; Sandula I; Kogan G
Bull Exp Biol Med; 2001 Aug; 132(2):787-90. PubMed ID: 11713568
[TBL] [Abstract][Full Text] [Related]
11. The antitumor effect of postoperative treatment with genistein alone or combined with cyclophosphamide in mice bearing transplantable tumors.
Wietrzyk J; Opolski A; Madej J; Radzikowski C
Acta Pol Pharm; 2000 Nov; 57 Suppl():5-8. PubMed ID: 11293263
[TBL] [Abstract][Full Text] [Related]
12. The antitumor effect of lowered doses of cytostatics combined with new analogs of vitamin D in mice.
Wietrzyk J; Nevozhay D; Filip B; Milczarek M; Kutner A
Anticancer Res; 2007; 27(5A):3387-98. PubMed ID: 17970085
[TBL] [Abstract][Full Text] [Related]
13. Anthrax-protective effects of yeast beta 1,3 glucans.
Kournikakis B; Mandeville R; Brousseau P; Ostroff G
MedGenMed; 2003 Mar; 5(1):1. PubMed ID: 12827062
[TBL] [Abstract][Full Text] [Related]
14. Beta-(1-3),(1-6)-D-glucan enhances the effect of low-dose cyclophosphamide treatment on A20 lymphoma in mice.
Harnack U; Eckert K; Pecher G
Anticancer Res; 2011 Apr; 31(4):1169-72. PubMed ID: 21508361
[TBL] [Abstract][Full Text] [Related]
15. Combined therapeutic effect of a monoclonal anti-idiotype tumor vaccine against NeuGc-containing gangliosides with chemotherapy in a breast carcinoma model.
Fuentes D; Avellanet J; Garcia A; Iglesias N; Gabri MR; Alonso DF; Vazquez AM; Perez R; Montero E
Breast Cancer Res Treat; 2010 Apr; 120(2):379-89. PubMed ID: 19377876
[TBL] [Abstract][Full Text] [Related]
16. Combination Therapy with Glucan and Coenzyme Q
Vetvicka V; Vetvickova J
Anticancer Res; 2018 Jun; 38(6):3291-3297. PubMed ID: 29848676
[TBL] [Abstract][Full Text] [Related]
17. Enhancing effect of new biological response modifier sulfoethylated (1-->3)-beta-D-glucan on antitumor activity of cyclophosphamide in the treatment of experimental murine leukoses.
Khalikova TA; Korolenko TA; Zhanaeva SY; Kaledin VI; Kogan G
Exp Oncol; 2006 Dec; 28(4):308-13. PubMed ID: 17285116
[TBL] [Abstract][Full Text] [Related]
18. Treating triple-negative breast cancer by a combination of rapamycin and cyclophosphamide: an in vivo bioluminescence imaging study.
Zeng Q; Yang Z; Gao YJ; Yuan H; Cui K; Shi Y; Wang H; Huang X; Wong ST; Wang Y; Kesari S; Ji RR; Xu X
Eur J Cancer; 2010 Apr; 46(6):1132-43. PubMed ID: 20156674
[TBL] [Abstract][Full Text] [Related]
19. An novel inhibitor of TGF-β type I receptor, IN-1130, blocks breast cancer lung metastasis through inhibition of epithelial-mesenchymal transition.
Park CY; Min KN; Son JY; Park SY; Nam JS; Kim DK; Sheen YY
Cancer Lett; 2014 Aug; 351(1):72-80. PubMed ID: 24887560
[TBL] [Abstract][Full Text] [Related]
20. Synergistic activity of recombinant human endostatin in combination with adriamycin: analysis of in vitro activity on endothelial cells and in vivo tumor progression in an orthotopic murine mammary carcinoma model.
Plum SM; Hanson AD; Volker KM; Vu HA; Sim BK; Fogler WE; Fortier AH
Clin Cancer Res; 2003 Oct; 9(12):4619-26. PubMed ID: 14555538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
